Gosset Calcium release-activated calcium channel Overview
The **Calcium release-activated calcium channel** (CRAC channel) is a highly selective ion channel in the plasma membrane that mediates calcium influx primarily in response to depletion of calcium stores in the endoplasmic reticulum. Its principal pore-forming subunit is Orai1 (with Orai2 and Orai3 as supportive subunits), activated by STIM1, the ER-luminal Ca2+ sensor[1][3][5]. Upon ER calcium depletion, STIM1 translocates to ER-plasma membrane junctions, oligomerizes, and directly interacts with Orai1 to open the CRAC channel, facilitating calcium influx (store-operated calcium entry, SOCE)[3][5]. CRAC channels play essential roles in immune cell activation, gene expression, migration, and secretion of inflammatory mediators, and are implicated in diverse diseases including immunodeficiency, autoimmunity, inflammation, cancer, and acute pancreatitis[3][5][6]. Loss-of-function mutations cause severe immunodeficiency and related syndromes, while inhibitors of CRAC channels are under development for inflammatory and autoimmune disorders as well as pancreatitis[4][6]. Therapeutic challenges include the risk of broad immunosuppression and calcium dysregulation in non-immune tissues[4][6].
Mechanism of Action
Inhibition of calcium influx by blocking Orai1/STIM1-mediated CRAC channel opening, Modulation of store-operated calcium entry, Suppression of downstream calcium-dependent signaling
Biological Functions
Disease Associations
Safety Considerations
- Risk of global immunosuppression
- Potential for infection susceptibility
- Calcium homeostasis disruption
- Off-target effects in non-immune tissues
- Lack of cell-type selectivity
- Potential for unintended effects in muscle or neurological tissue
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| ORAI1, STIM1 expression levels |
| Orai1/STIM1 mutations |
| Serum carcinoembryonic antigen in colorectal cancer (when researched as indirect cancer-prognostic marker) |